DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Catumaxomab is an investigational drug.
There have been 13 clinical trials for Catumaxomab. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2008.
The most common disease conditions in clinical trials are Ascites, Ovarian Neoplasms, and Adenocarcinoma. The leading clinical trial sponsors are Neovii Biotech, Fresenius Biotech North America, and AIO-Studien-gGmbH.
Recent Clinical Trials for Catumaxomab
|Feasibility and Clinical Activity of Initial Intraperitoneal Catumaxomab Followed by Chemotherapy in Patients With Recurrent Ovarian Cancer||JSehouli||Phase 2|
|Treatment of Gastric Peritoneal Carcinomatosis by Association of Complete Surgical Resection of the Lesions and Intraperitoneal Immunotherapy Using Catumaxomab||Gustave Roussy, Cancer Campus, Grand Paris||Phase 2|
|Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas||Neovii Biotech||Phase 2|